SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating 23andMe Holding Co. for Potential Breaches of Fiduciary Duty By Its Board of DirectorsPRNewsWire • 07/31/23
23andMe Releases New FDA-Cleared Genetic Report on Simvastatin, a Commonly Prescribed StatinGlobeNewsWire • 07/20/23
23andMe Releases New Report Revealing Genetic Likelihood of Experiencing Panic AttacksGlobeNewsWire • 06/21/23
23andMe: Revenue Growth And Secular Trend, But Lack Of Profits Makes It A HoldSeeking Alpha • 06/15/23
New 23andMe survey reveals nine out of ten physicians in the U.S. believe genetics play an important part of a patient's complete health pictureGlobeNewsWire • 05/16/23
23andMe Announces Phase 1 Results from the First-in-Human Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1GlobeNewsWire • 04/14/23
Morehouse School of Medicine, Sickle Cell Foundation of Georgia and 23andMe Launch Sickle Cell Carrier Status Awareness ProgramGlobeNewsWire • 04/11/23
23andMe Aims To Raise Awareness of Lipoprotein(a), a Little-Known Genetic Risk Factor for Cardiovascular DiseaseGlobeNewsWire • 03/24/23